Back to 
Los Angeles Capital Management LLC
Los Angeles Capital Management LLC
NTLA
Showing 4 of 22 quarters
Position history for Los Angeles Capital Management LLC's holdings in Intellia Therapeutics, Inc.
Yes. Los Angeles Capital Management holds 617 shares of NTLA (Intellia Therapeutics), worth $10,440, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Los Angeles Capital Management has held NTLA since Q4 2025, across 3 quarterly 13F filings.
Current Value
$10,440
Current Shares
617
Total Value Change
+$10,440
Total Shares Change
+617
Quarter-by-Quarter History